Key result
PTMC increases mitral valve area ~67% and lowers pulmonary artery pressure in severe mitral stenosis.
Case Report (n=1)
No
PTMC can be a viable palliative strategy for severe rheumatic mitral stenosis, even in patients with extremely low valve area and high-risk morphology who refuse surgery.
PTMC may be feasible in extreme mitral stenosis by experienced operators; case report leaves open need for prospective validation.
We present a detailed case of a 39-year-old male patient with severe, symptomatic rheumatic mitral stenosis who was successfully treated with percutaneous transvenous mitral commissurotomy (PTMC) at Milad Hospital in Isfahan, Iran. The patient presented with chronic dyspnea on exertion (New York Heart Association class III) and fatigue, and pre-procedural two-dimensional and three-dimensional echocardiography confirmed a critically low mitral valve area (MVA) of 0.36 cm \({}²\) (3D planimetry with multiplanar reconstruction) and a challenging valve morphology, as assessed by a high Wilkins score of 10 and a 3D echocardiographic score of 8. The PTMC procedure, performed with an Inoue balloon, was uneventful and resulted in a marked improvement in valve function, with the MVA increasing to \(0.6 cm²\) and the systolic pulmonary artery pressure decreasing from 45 mmHg to 30 mmHg. Mitral regurgitation remained trivial/mild (grade 1+) throughout. At one-month follow-up, the patient was in NYHA class II and the MVA remained stable. This case highlights that PTMC remains a highly effective and safe intervention for severe mitral stenosis, even in patients with high-risk valve morphology, when performed by experienced operators in a specialized tertiary care center and guided by a multidisciplinary Heart Team.
No takes yet. Share an insight, caveat, or question.
Mansouri et al. (2026) conducted a case report in Severe rheumatic mitral stenosis (n=1). Percutaneous transvenous mitral commissurotomy (PTMC) was evaluated on Mitral valve area (MVA) and systolic pulmonary artery pressure. Percutaneous transvenous mitral commissurotomy increased mitral valve area from 0.36 to 0.6 cm2 and reduced systolic pulmonary artery pressure from 45 to 30 mmHg.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: